跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
卫喜康 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Solifenacin Succinate Tablets
Approved
化学药品
Solifenacin Succinate Tablets
ASTELLAS PHARMA EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
May 29, 2023
Approval ID
8TEL7tyuFP5
Company
ASTELLAS PHARMA EUROPE B.V.
Type
化学药品
Approval Details
Approval Id
8TEL7tyuFP5
Approval Number
国药准字HJ20140209
Generic Name
琥珀酸索利那新片
Generic Name En
Solifenacin Succinate Tablets
Trade Name
卫喜康
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg
Reg Date
2023-05-29
Expired Date
2028-05-28
Company Name
ASTELLAS PHARMA EUROPE B.V.
Production Company Name
ASTELLAS PHARMA EUROPE B.V.
Company Detail Path
/organization/astellas-pharma-europe-b-v
Production Company Detail Path
/organization/astellas-pharma-europe-b-v
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 29, 2023
Approval ID
8TEL7tyuFP5
Type
化学药品
Back to NMPA Approvals